Alimentary Pharmacology & Therapeutics

Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists
pp. 163-171(9)
Author: REX, D. K.

Review article: the pathogenesis and management of eosinophilic oesophagitis
pp. 173-182(10)
Authors: FURUTA, G. T.; STRAUMANN, A.

Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective
pp. 183-205(23)
Authors: TACK, J.; FRIED, M.; HOUGHTON, L. A.; SPICAK, J.; FISHER, G.

Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome - a European perspective
pp. 207-236(30)
Authors: HEADING, R.; BARDHAN, K.; HOLLERBACH, S.; LANAS, A.; FISHER, G.

Systematic review: sphincter of Oddi dysfunction - non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy
pp. 237-246(10)
Authors: SGOUROS, S. N.; PEREIRA, S. P.

Systematic review: the treatment of anal fissure
pp. 247-257(11)
Authors: STEELE, S. R.; MADOFF, R. D.

Systematic review: the impact of gastro-oesophageal reflux disease on work productivity
pp. 259-272(14)
Authors: WAHLQVIST, P.; REILLY, M. C.; BARKUN, A.

Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection
pp. 273-280(8)
Authors: SUZUKI, T.; MATSUO, K.; SAWAKI, A.; ITO, H.; HIROSE, K.; WAKAI, K.; SATO, S.; NAKAMURA, T.; YAMAO, K.; UEDA, R.; TAJIMA, K.

Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma
pp. 281-291(11)
Authors: BJELAKOVIC, G.; NAGORNI, A.; NIKOLOVA, D.; SIMONETTI, R. G.; BJELAKOVIC, M.; GLUUD, C.

Guidelines for capsule endoscopy: diagnoses will be missed
pp. 293-297(5)
Authors: MAKINS, R.; BLANSHARD, C.

Validation of administrative data used for the diagnosis of upper gastrointestinal events following nonsteroidal anti-inflammatory drug prescription
pp. 299-306(8)
Authors: ABRAHAM, N. S.; COHEN, D. C.; RIVERS, B.; RICHARDSON, P.

Papillotomy Performance Scoring Scale - a pilot validation study focused on the cut axis
pp. 307-312(6)
Authors: LEUNG, J. W.; LEUNG, F. W.

Prospective assessment of the impact of feedback on colonoscopy performance
pp. 313-318(6)
Authors: HAREWOOD, G. C.; PETERSEN, B. T.; OTT, B. J.

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort
pp. 319-330(12)
Authors: HO, G.-T.; CHIAM, P.; DRUMMOND, H.; LOANE, J.; ARNOTT, I. D. R.; SATSANGI, J.

Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
pp. 331-342(12)
Authors: HINDORF, U.; LINDQVIST, M.; HILDEBRAND, H.; FAGERBERG, U.; ALMER, S.

Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease
pp. 343-350(8)
Authors: SCHMIDT, C.; WITTIG, B. M.; MOSER, C.; ZEITZ, M.; STALLMACH, A.

Infliximab therapy in Crohn's disease: a pragmatic approach?
pp. 351-359(9)
Authors: KEVANS, D.; KEEGAN, D.; MULCAHY, H. E.; O'DONOGHUE, D. P.

Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias
pp. 361-370(10)
Authors: CUOMO, R.; DE GIORGI, F.; ADINOLFI, L.; SARNELLI, G.; LOFFREDO, F.; EFFICIE, E.; VERDE, C.; SAVARESE, M. F.; USAI, P.; BUDILLON, G.

Predictors of treatment response in patients with non-erosive reflux disease
pp. 371-376(6)
Authors: TALLEY, N. J.; ARMSTRONG, D.; JUNGHARD, O.; WIKLUND, I.

Persistence and adherence to proton pump inhibitors in daily clinical practice
pp. 377-385(9)
Authors: VAN SOEST, E. M.; SIERSEMA, P. D.; DIELEMAN, J. P.; STURKENBOOM, M. C. J. M.; KUIPERS, E. J.

Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure
pp. 387-394(8)
Authors: DE MARCO, G.; SORDINO, D.; BRUZZESE, E.; DI CARO, S.; MAMBRETTI, D.; TRAMONTANO, A.; COLOMBO, C.; SIMONI, P.; GUARINO, A.

Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin
pp. 395-403(9)
Authors: MIEHLKE, S.; HANSKY, K.; SCHNEIDER-BRACHERT, W.; KIRSCH, C.; MORGNER, A.; MADISCH, A.; KUHLISCH, E.; BÄSTLEIN, E.; JACOBS, E.; BAYERDÖRFFER, E.; LEHN, N.; STOLTE, M.

Disturbed bowel habits in patients with non-ulcer dyspepsia
pp. 405-410(6)
Authors: HAMMER, J.; TALLEY, N. J.

Prevalence and management of abdominal cramping and pain: a multinational survey
pp. 411-419(9)
Authors: QUIGLEY, E. M. M.; LOCKE, G. R.; MUELLER-LISSNER, S.; PAULO, L. G.; TYTGAT, G. N.; HELFRICH, I.; SCHAEFER, E.

Healthcare seeking for constipation: a population-based survey in the Mediterranean area of Spain
pp. 421-428(8)
Authors: GÁLVEZ, C.; GARRIGUES, V.; ORTIZ, V.; PONCE, M.; NOS, P.; PONCE, J.

Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome
pp. 429-438(10)
Authors: LU, C.-L.; CHANG, F.-Y.; CHEN, C.-Y.; LUO, J.-C.; LEE, S.-D.

Errata
pp. 439-439(1)

Errata
pp. 439-439(1)